SUPREME CANNABIS Price to Sales

<div class='logoBackup' style='background:#FCD202;color: white;font-size:3em;;'>SPR</div>
SPRWF -- USA Stock  

USD 0.43  0.028  6.11%

SUPREME CANNABIS price-to-sales fundamental analysis lookup allows you to check this and other indicators for SUPREME CANNABIS INC or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools
Symbol
Refresh

SUPREME CANNABIS Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis
SUPREME CANNABIS Price to Sales  =
40.84 
ValuationFundamentalsBuy or Sell

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition
Based on latest financial disclosure the price to sales indicator of SUPREME CANNABIS INC is roughly 40.84 times. This is 90.84% higher than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?Specialty & Generic industry, The Price to Sales for all stocks is 257.62% lower than the firm.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

SUPREME CANNABIS current financial ratios